
Tourmaline Bio Inc.
TRML | NASDAQ
$47.98
$0 (0.00%)
At close: Oct 28, 2025, 4:00 PM ET
+0.00%
(1D)Key Statistics
Market Data
Market Cap $1.23B
1D Range
47.98 47.98
52W Range
11.56 48.27
Valuation (TTM)
PE -13.99
PB 4.76
EV/EBITDA -9.70
Valuation (NTM)
Forward PE N/A
Forward PEG -1.79
Price Target $48.50
Cash Flow
FCF Yield -7.0%
SBC Adj. FCF Yield -7.7%
SBC Impact -9.4%
Margins
Gross Margin 0.0%
Operating Margin -256122.5%
FCF Margin -215752.5%
Growth (CAGR)
Revenue 3Y | 5Y 2.6% |
50.9%
Dil EPS 3Y | 5Y -35.3% |
61.1%
FCF 3Y | 5Y -52.0% |
-19.7%
Returns
ROA -17.1%
ROE -17.1%
ROIC -20.1%
Financial Health
Net Cash
$239.09M
Current Ratio 24.68
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
A detailed description of the company is not yet available.
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove TRML